> Home    > Preclinical Studies     > Clinical Program     > QC Technology     > Corporate Overview     > Newsroom
 
 
Patent Portfolio
 
Product Development Patents
 

“Herbal Composition PHY906 and Its Use in Chemotherapy” (Parent)
Approved: Singapore, Patent No. 91598 (2005), U.S., Patent No. 7,025,993 (2006)
Allowed:  Australia
Pending: Canada, China, Europe, Hong Kong, Japan, South Korea, Taiwan

 

“Herbal Composition PHY906 and Its Use in Chemotherapy (CIP)
Pending: Australia, Canada, China, Europe, Japan, Taiwan, United States

 

“Icariin Preparations”  
Approved: U.S., Patent No. 6,123,944 (2000)

 
QC Technology Patents
 

“Phytomics: A Genomic-Based Approach to Herbal Compositions” (1998)
Approved: Australia, Patent No. 779424 (2005), Singapore,Patent No. 80503 (2004),
South Korea, Patent No. 470379 (2005), Taiwan, Patent No. 89104268 (2005)
Pending: Hong Kong, Japan, U.S.

 

“Methods to Quantitatively Assess the Properties of Botanical Samples for the Purpose of Effective Quality Control and Drug Discovery”
Approved:  Taiwan, Patent No. I275792 (2007)
Pending: Hong Kong, U.S.

 

PhytoCeutica, Inc. 5 Science Park, Suite 13,New Haven, CT  06511, Phone: 203-777-3462, Fax: 203-777-3538

E-mail: info@phytoceutica.com

www.audinwebdesign.com